Logo

OpiCalc

FavoritesSpecialtiesDrugsGuidelinesMost Used

All Specialties

OpiCalc Logo
FavoritesSpecialtiesDrugsGuidelinesMost Used
FavesSpecsDrugsGuidesTop
BPH Impact IndexBosniak ClassificationCAPRA ScoreD'Amico Risk ClassificationEAU NMIBC Risk Groups (2021)EORTC Risk Tables for NMIBCFournier's Gangrene Severity IndexGUPI (Genitourinary Pain Index)Guy's Stone ScoreICIQ-UI SFIGCCCG ClassificationIIEF-5 / SHIMIIQ-7IMDC (Heng) Risk CriteriaIPSS ScoreNIH-CPSIOAB-V8PADUA Prediction ScorePI-RADS v2.1PSA DensityR.E.N.A.L. Nephrometry ScoreResidual Volume (PVR)S.T.O.N.E. NephrolithometrySFU Hydronephrosis GradingUDI-6VUR Grading
OpiCalc Logo

OpiCalc

Easy, fast, and private medical tools for clinicians. Always free.

No Login Required
Ready for the Bedside

Resources

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of UseCookie Policy

Support

Contact Us

Clinical Notice:OpiCalc is not a substitute for professional clinical judgment. Always verify dosages and guidelines.

OpiCalc © 2018-2026

•

All Rights Reserved

Recent Journal Updates

Cancer MedicineJun 19, 2026
Association of Lipid and Inflammatory Profiles With Tumor Stage in Hepatocellular Carcinoma

Clinical Context

We think this has broad domain relevance to R.E.N.A.L. Nephrometry Score.

Alzheimers & DementiaJun 17, 2026
WSB.APP/PS1 mice develop age‐dependent cerebral amyloid angiopathy, cerebrovascular dysfunction, and white matter deficits

Clinical Context

We think this has broad domain relevance to R.E.N.A.L. Nephrometry Score.

JAMAJun 16, 2026
Eating Less Protein May Improve Outcomes for Patients With Kidney Disease

Clinical Context

We think this has broad domain relevance to R.E.N.A.L. Nephrometry Score.

R.E.N.A.L. Nephrometry Score

R.E.N.A.L. Anatomy Classification

Scoring Parameters

Awaiting Selections

Complete all parameters including orientation to calculate the nephrometry score.

Guidelines & Evidence

Verified

Last Review: 2026

When to Use

When to Calculate R.E.N.A.L. Nephrometry Score

Preoperative assessment of renal masses being considered for partial nephrectomy (PN) vs radical nephrectomy (RN)
Risk stratification and patient counseling regarding perioperative complications and warm ischemia time
Surgical planning: approach (open, laparoscopic, robotic), number of arteries, and expected difficulty
Comparison of outcomes across institutions and surgeons in academic series
Decision-making in patients with solitary kidney, bilateral tumors, or chronic kidney disease (CKD)
Research and tumor board discussions for small renal masses (SRM)
Longitudinal tracking of tumor complexity in active surveillance protocols

Clinical Context

The incidence of renal cell carcinoma (RCC) continues to rise due to increased cross-sectional imaging. Most renal masses today are discovered incidentally and are small (<4 cm). Partial nephrectomy is the preferred approach for T1 tumors when technically feasible, as it preserves renal function and reduces cardiovascular risk compared to radical nephrectomy. The R.E.N.A.L. Nephrometry Score provides an objective, reproducible method to quantify tumor complexity and helps standardize reporting and decision-making.

Ideal Candidates for Partial Nephrectomy

Clinical T1a tumors (≤4 cm)
Low to moderate R.E.N.A.L. score (4–9)
Good preoperative renal function (eGFR >60)
No absolute indications for radical nephrectomy (e.g., tumor thrombus)
Patient preference for nephron-sparing surgery

Last Comprehensive Review: 2026

Related Tools

PADUA Prediction Score
Bosniak Classification
Urology CalculatorsInternal Medicine CalculatorsEmergency Medicine Calculators
Have feedback about this calculator?Let us know.